Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis

Dentomaxillofacial Radiology

Volumn 40, Issue 8, 2011, Pages 501-505

  Torres, S R ^a   Chen, C S K ^b   Leroux, B G ^c   Lee, P P ^c   Hollender, L G ^a   Schubert, M M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Division of Oral Radiology   (United States)

^c Dental Public Health Sciences and Biostatistics ^*  (United States)

Author keywords

Bisphosphonates; Cone beam computed tomography; Fractals; Jaw abnormalities; Osteonecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; ARTICLE; BONE NECROSIS; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CONE BEAM COMPUTED TOMOGRAPHY; FEMALE; FRACTAL ANALYSIS; HUMAN; JAW DISEASE; MALE; METHODOLOGY; MIDDLE AGED; PILOT STUDY; RADIOGRAPHY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; CONE-BEAM COMPUTED TOMOGRAPHY; DIPHOSPHONATES; FEMALE; FRACTALS; HUMANS; LOGISTIC MODELS; MALE; MANDIBULAR DISEASES; MIDDLE AGED; OSTEONECROSIS; PILOT PROJECTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 82755186825     PISSN: 0250832X     EISSN: None     Source Type: Journal    
DOI: 10.1259/dmfr/14636637     Document Type: Article

References (23)

1. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945-952. (Pubitemid 46638849)
2. Miglioratti C, Schubert MM, Peterson DE, Seneda M. Associated osteonecrosis of mandibular and maxillary bone. An emerging oral complication of supportive cancer therapy. Cancer 2005; 104: 83-93. (Pubitemid 40847755)
3. Petrut B, Trinkaus M, Simmons C, Clemons M. A primer of bone metastases management in breast cancer patients. Curr Oncol 2008; 15: S50-S57.
4. Brufsky A. Bone health issues in women with early-stage breast cancer receiving aromatase inhibitors. Curr Oncol Rep 2008; 10: 18-26.
5. Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 2009; 67: 75-84.
6. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22: 1479-1491. (Pubitemid 351229318)
7. Kumar V, Pass B, Guttenberg SA, Ludlow J, Emery RW, Tyndall DA, et al. Bisphosphonate-related osteonecrosis of the jaws. A report of three cases demonstrating variability in outcomes and morbidity. J Am Dent Assoc 2007; 138: 602-609.
8. Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 249-258.
9. Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol 2008; 63: 71-77. (Pubitemid 350212865)
10. Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, et al. Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Ann Hematol 2007; 86: 415-423. (Pubitemid 46630059)
11. Greenspan SL, Perera S, Recker R, Wagner JM, Greeley P, Gomberg BR, et al. Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy. Bone 2010; 46: 1006-1010.
12. Wilde F, Steinhoff K, Frerich B, Schulz T, Winter K, Hemprich A, et al. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 412-419.
13. Bollen AM, Taguchi A, Hujoel PP, Hollender LG. Fractal dimension on dental radiographs. Dentomaxillofac Radiol 2001; 30: 270-275. (Pubitemid 33695417)
14. Chen SK, Oviir T, Lin CH, Leu LJ, Cho BH, Hollender L. Digital imaging analysis with mathematical morphology and fractal dimension for evaluation of periapical lesions following endodontic treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 467-472. (Pubitemid 41331037)
15. Yu YY, Chen H, Lin CH, Chen CM, Oviir T, Chen SK, et al. Fractal dimension analysis of periapical reactive bone in response to root canal treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 283-288.
16. Bollen AM, Taguchi A, Hujoel PP, Hollender LG. Case-control study on self-reported osteoporotic fractures and mandibular cortical bone. Oral Surg Oral Med Oral Path Oral Radiol Endod 2000; 90: 518-524.
17. Bedogni A, Blandamura S, Lokmic Z, Palumbo C, Ragazzo M, Ferrari F, et al. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 358-364.
18. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonateassociated osteonecrosis of the jaws. Dentomaxillofac Radiol 2006; 35: 236-243. (Pubitemid 44076879)
19. Phal PM, Myall RW, Assael LA, Weissman JL. Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol 2007; 28: 1139-1145. (Pubitemid 46984558)
20. Southard KA, Southard TE. Detection of simulated osteoporosis in human anterior maxillary alveolar bone using digital subtraction. Oral Surg Oral Med Oral Pathol 1994; 78: 655-661.
21. Berenson JR, Yellin O, Boccia RV, Flam M, Wong SF, Batuman O, et al. Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss. Clin Cancer Res 2008; 14: 6289-6295.
22. Israeli RS, Rosenberg SJ, Saltzstein DR, Gottesman JE, Goldstein HR, Hull GW, et al. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy. Clin Genitourin Cancer 2007; 5: 271-277. (Pubitemid 46867363)
23. Lane N, Armitage GC, Loomer P, Hsieh S, Majumdar S, Wang HY, et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005; 76: 1113-1122. (Pubitemid 41065401)